Osaic Holdings
BEAM icon

Osaic Holdings’s Beam Therapeutics BEAM Stock Holding History

Osaic Holdings’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Sell
4,190
-1,317
-24% -$39.8K ﹤0.01% 4678
2026
Q1 		$131K Sell
5,507
-148
-3% -$4.11K ﹤0.01% 4483
2025
Q4 		$157K Sell
5,655
-1,133
-17% -$28.9K ﹤0.01% 4342
2025
Q3 		$143K Buy
6,788
+208
+3% +$4.14K ﹤0.01% 4489
2025
Q2 		$112K Buy
6,580
+524
+9% +$9.13K ﹤0.01% 4415
2025
Q1 		$118K Buy
6,056
+1,614
+36% +$42.3K ﹤0.01% 4052
2024
Q4 		$110K Sell
4,442
-9,149
-67% -$233K ﹤0.01% 4099
2024
Q3 		$333K Buy
13,591
+671
+5% +$17.3K ﹤0.01% 3222
2024
Q2 		$303K Sell
12,920
-1,048
-8% -$25.7K ﹤0.01% 3209
2024
Q1 		$462K Sell
13,968
-2,746
-16% -$85.6K ﹤0.01% 3000
2023
Q4 		$455K Buy
16,714
+3,374
+25% +$83.8K ﹤0.01% 3246
2023
Q3 		$321K Buy
13,340
+228
+2% +$6.11K ﹤0.01% 3625
2023
Q2 		$419K Sell
13,112
-409
-3% -$13.3K ﹤0.01% 3294
2023
Q1 		$414K Sell
13,521
-721
-5% -$28.5K ﹤0.01% 3256
2022
Q4 		$556K Buy
14,242
+2,443
+21% +$109K ﹤0.01% 2928
2022
Q3 		$561K Sell
11,799
-3,090
-21% -$176K ﹤0.01% 2780
2022
Q2 		$578K Buy
14,889
+418
+3% +$16.6K ﹤0.01% 2778
2022
Q1 		$823K Buy
14,471
+199
+1% +$13.1K ﹤0.01% 2753
2021
Q4 		$1.14M Sell
14,272
-5,247
-27% -$449K ﹤0.01% 2278
2021
Q3 		$1.7M Buy
19,519
+2,413
+14% +$242K ﹤0.01% 1861
2021
Q2 		$2.21M Buy
17,106
+4,108
+32% +$327K ﹤0.01% 1616
2021
Q1 		$1.04M Buy
12,998
+4,212
+48% +$401K ﹤0.01% 2197
2020
Q4 		$717K Sell
8,786
-389
-4% -$19.1K ﹤0.01% 2326
2020
Q3 		$226K Buy
9,175
+150
+2% +$3.72K ﹤0.01% 3128
2020
Q2 		$253K Buy
+9,025
New +$194K ﹤0.01% 2921

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Osaic Holdings's BEAM Position: Q2 2026 in Review

Osaic Holdings reduced its Beam Therapeutics (BEAM) stake by 24% in Q2 2026, selling an estimated $39.8K and leaving 4,190 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #4678.

Osaic Holdings first reported a position in BEAM in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.21M in Q2 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Osaic Holdings held 4,190 shares of Beam Therapeutics worth $144K as of Q2 2026.
  • Osaic Holdings sold 1,317 Beam Therapeutics shares in Q2 2026, an estimated $39.8K.
  • Beam Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4678 holding.
  • Osaic Holdings first reported a position in Beam Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Beam Therapeutics position peaked at $2.21M in Q2 2021.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.